Cargando…
Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging
Triple-negative breast cancer (TNBC) is characterized by aggressiveness and high rates of metastasis. The identification of relevant biomarkers is crucial to improve outcomes for TNBC patients. Membrane type 1-matrix metalloproteinase (MT1-MMP) could be a good candidate because its expression has be...
Autores principales: | Mulero, Francisca, Oteo, Marta, Garaulet, Guillermo, Magro, Natalia, Rebollo, Lluvia, Medrano, Guillermo, Santiveri, Clara, Romero, Eduardo, Sellek, Ricela E., Margolles, Yago, Campos-Olivas, Ramón, Arroyo, Alicia G., Fernández, Luis Angel, Morcillo, Miguel Angel, Martínez-Torrecuadrada, Jorge L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729729/ https://www.ncbi.nlm.nih.gov/pubmed/36507540 http://dx.doi.org/10.3389/fmed.2022.1058455 |
Ejemplares similares
-
Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas
por: de Lucas, A. G., et al.
Publicado: (2016) -
Editorial: ImmunoPET imaging in disease diagnosis and therapy assessment
por: Mulero, Francisca
Publicado: (2023) -
MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management
por: Morcillo, Miguel Ángel, et al.
Publicado: (2018) -
Imaging PD-L1 Expression with ImmunoPET
por: Truillet, Charles, et al.
Publicado: (2017) -
ImmunoPET imaging of human CD8(+) T cells with novel (68)Ga-labeled nanobody companion diagnostic agents
por: Zhao, Haitao, et al.
Publicado: (2021)